Literature DB >> 30146242

Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11.

Jing Li1, Yaru Zhang2, Bruno Da Silva Sil Dos Santos3, Feng Wang4, Yuyong Ma5, Christian Perez5, Yanling Yang6, Junmin Peng6, Seth M Cohen5, Tsui-Fen Chou4, Stephen T Hilton7, Raymond J Deshaies8.   

Abstract

The 26S proteasome is the major proteolytic machine for breaking down cytosolic and nuclear proteins in eukaryotes. Due to the lack of a suitable assay, it is difficult to measure routinely and quantitatively the breakdown of proteins by the 26S proteasome in vitro. In the present study, we developed an assay to monitor proteasome-mediated protein degradation. Using this assay, we discovered that <span class="Chemical">epidithiodiketopiperazine (ETPs) blocked the degradation of our model substrate in vitro. Further characterization revealed that ETPs inhibited proteasome function by targeting the essential proteasomal deubiquitinase Rpn11 (POH1/PSMD14). ETPs also inhibited other JAMM (JAB1/MPN/Mov34 metalloenzyme) proteases such as Csn5 and AMSH. An improved ETP with fewer non-specific effects, SOP11, stabilized a subset of proteasome substrates in cells, induced the unfolded protein response, and led to cell death. SOP11 represents a class of Rpn11 inhibitor and provides an alternative route to develop proteasome inhibitors.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Capzimin; JAMM protease; POH1; PSMD14; Rpn11; epidithiodiketopiperazine; gliotoxin; proteasome; protein degradation; ubiquitin

Mesh:

Substances:

Year:  2018        PMID: 30146242      PMCID: PMC6309308          DOI: 10.1016/j.chembiol.2018.07.012

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  41 in total

1.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

2.  K63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1.

Authors:  Eric M Cooper; Colleen Cutcliffe; Troels Z Kristiansen; Akhilesh Pandey; Cecile M Pickart; Robert E Cohen
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

3.  Polyubiquitination by HECT E3s and the determinants of chain type specificity.

Authors:  Hyung Cheol Kim; Jon M Huibregtse
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

Review 4.  Current treatment landscape for relapsed and/or refractory multiple myeloma.

Authors:  Meletios A Dimopoulos; Paul G Richardson; Philippe Moreau; Kenneth C Anderson
Journal:  Nat Rev Clin Oncol       Date:  2014-11-25       Impact factor: 66.675

5.  Selective inactivation of glutaredoxin by sporidesmin and other epidithiopiperazinediones.

Authors:  Usha Srinivasan; Aveenash Bala; Shu-chuan Jao; David W Starke; T William Jordan; John J Mieyal
Journal:  Biochemistry       Date:  2006-07-25       Impact factor: 3.162

6.  Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.

Authors:  Kristina M Cook; Stephen T Hilton; Jasmin Mecinovic; William B Motherwell; William D Figg; Christopher J Schofield
Journal:  J Biol Chem       Date:  2009-07-09       Impact factor: 5.157

7.  Sporidesmin and gliotoxin induce cell detachment and perturb microfilament structure in cultured liver cells.

Authors:  T W Jordan; J S Pedersen
Journal:  J Cell Sci       Date:  1986-09       Impact factor: 5.285

8.  Quantitative cell-based protein degradation assays to identify and classify drugs that target the ubiquitin-proteasome system.

Authors:  Tsui-Fen Chou; Raymond J Deshaies
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

9.  Using transcriptome sequencing to identify mechanisms of drug action and resistance.

Authors:  Sarah A Wacker; Benjamin R Houghtaling; Olivier Elemento; Tarun M Kapoor
Journal:  Nat Chem Biol       Date:  2012-02-12       Impact factor: 15.040

10.  The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases.

Authors:  Isabel Saez; David Vilchez
Journal:  Curr Genomics       Date:  2014-02       Impact factor: 2.236

View more
  14 in total

1.  Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening.

Authors:  Aayush Gupta; Huan-Xiang Zhou
Journal:  J Chem Inf Model       Date:  2021-08-17       Impact factor: 6.162

Review 2.  Understanding the 26S proteasome molecular machine from a structural and conformational dynamics perspective.

Authors:  Eric R Greene; Ken C Dong; Andreas Martin
Journal:  Curr Opin Struct Biol       Date:  2019-11-26       Impact factor: 6.809

Review 3.  Breaking the chains: deubiquitylating enzyme specificity begets function.

Authors:  Michael J Clague; Sylvie Urbé; David Komander
Journal:  Nat Rev Mol Cell Biol       Date:  2019-06       Impact factor: 94.444

4.  Identification of Adenosine Deaminase Inhibitors by Metal-binding Pharmacophore Screening.

Authors:  Rebecca N Adamek; Paul Ludford; Stephanie M Duggan; Yitzhak Tor; Seth M Cohen
Journal:  ChemMedChem       Date:  2020-10-14       Impact factor: 3.466

Review 5.  Proteasome interaction with ubiquitinated substrates: from mechanisms to therapies.

Authors:  Xiang Chen; Zaw Min Htet; Erika López-Alfonzo; Andreas Martin; Kylie J Walters
Journal:  FEBS J       Date:  2020-12-11       Impact factor: 5.622

Review 6.  Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease.

Authors:  David J Sherman; Jing Li
Journal:  Molecules       Date:  2020-02-05       Impact factor: 4.411

Review 7.  Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.

Authors:  Huanjie Yang; Xin Chen; Kai Li; Hassan Cheaito; Qianqian Yang; Guojun Wu; Jinbao Liu; Q Ping Dou
Journal:  Semin Cancer Biol       Date:  2019-12-26       Impact factor: 15.707

Review 8.  Small molecules that target the ubiquitin system.

Authors:  Hai Qiu Wu; David Baker; Huib Ovaa
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

9.  Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer.

Authors:  Claudia M Kowolik; Min Lin; Jun Xie; Larry E Overman; David A Horne
Journal:  J Exp Clin Cancer Res       Date:  2019-10-28

10.  Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance.

Authors:  Ling Zhang; Hui Xu; Chunping Ma; Jieru Zhang; Yuanjie Zhao; Xiaomei Yang; Shusheng Wang; Dawei Li
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.